항-BCMA 중쇄-단독 항체

항-BCMA 중쇄-단독 항체

본원에 기재된 항-BCMA 중쇄-단독 항체 (HCAb), 및 이러한 항체의 제조 방법, 조성물 (이러한 항체를 포함하는 약학적 조성물 포함), 및 BCMA의 발현을 특징으로 하는 B-세포 장애의 치료에 대한 이들의 사용. Anti-BCMA heavy chain-only antibodies (HCAb) and disclosed, along with methods of making such antibodies, compositions, including pharmaceutical compositions, comprising such a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DANG KEVIN, HARRIS KATHERINE E, TRINKLEIN NATHAN, VANSCHOOTEN WIM, ALDRED SHELLEY FORCE
Format: Patent
Sprache:kor
Schlagworte:
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DANG KEVIN
HARRIS KATHERINE E
TRINKLEIN NATHAN
VANSCHOOTEN WIM
ALDRED SHELLEY FORCE
description 본원에 기재된 항-BCMA 중쇄-단독 항체 (HCAb), 및 이러한 항체의 제조 방법, 조성물 (이러한 항체를 포함하는 약학적 조성물 포함), 및 BCMA의 발현을 특징으로 하는 B-세포 장애의 치료에 대한 이들의 사용. Anti-BCMA heavy chain-only antibodies (HCAb) and disclosed, along with methods of making such antibodies, compositions, including pharmaceutical compositions, comprising such antibodies, and their use to treat B-cell disorders characterized by the expression of BCMA.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20190117489A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20190117489A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20190117489A3</originalsourceid><addsrcrecordid>eNrjZJB9O3WtrpOzr6PCmyUT37S36L7uXvG6v1UBKPxm0xYeBta0xJziVF4ozc2g7OYa4uyhm1qQH59aXJCYnJqXWhLvHWRkYGhpYGhobmJh6WhMnCoAk8cqhg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>항-BCMA 중쇄-단독 항체</title><source>esp@cenet</source><creator>DANG KEVIN ; HARRIS KATHERINE E ; TRINKLEIN NATHAN ; VANSCHOOTEN WIM ; ALDRED SHELLEY FORCE</creator><creatorcontrib>DANG KEVIN ; HARRIS KATHERINE E ; TRINKLEIN NATHAN ; VANSCHOOTEN WIM ; ALDRED SHELLEY FORCE</creatorcontrib><description>본원에 기재된 항-BCMA 중쇄-단독 항체 (HCAb), 및 이러한 항체의 제조 방법, 조성물 (이러한 항체를 포함하는 약학적 조성물 포함), 및 BCMA의 발현을 특징으로 하는 B-세포 장애의 치료에 대한 이들의 사용. Anti-BCMA heavy chain-only antibodies (HCAb) and disclosed, along with methods of making such antibodies, compositions, including pharmaceutical compositions, comprising such antibodies, and their use to treat B-cell disorders characterized by the expression of BCMA.</description><language>kor</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20191016&amp;DB=EPODOC&amp;CC=KR&amp;NR=20190117489A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20191016&amp;DB=EPODOC&amp;CC=KR&amp;NR=20190117489A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DANG KEVIN</creatorcontrib><creatorcontrib>HARRIS KATHERINE E</creatorcontrib><creatorcontrib>TRINKLEIN NATHAN</creatorcontrib><creatorcontrib>VANSCHOOTEN WIM</creatorcontrib><creatorcontrib>ALDRED SHELLEY FORCE</creatorcontrib><title>항-BCMA 중쇄-단독 항체</title><description>본원에 기재된 항-BCMA 중쇄-단독 항체 (HCAb), 및 이러한 항체의 제조 방법, 조성물 (이러한 항체를 포함하는 약학적 조성물 포함), 및 BCMA의 발현을 특징으로 하는 B-세포 장애의 치료에 대한 이들의 사용. Anti-BCMA heavy chain-only antibodies (HCAb) and disclosed, along with methods of making such antibodies, compositions, including pharmaceutical compositions, comprising such antibodies, and their use to treat B-cell disorders characterized by the expression of BCMA.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJB9O3WtrpOzr6PCmyUT37S36L7uXvG6v1UBKPxm0xYeBta0xJziVF4ozc2g7OYa4uyhm1qQH59aXJCYnJqXWhLvHWRkYGhpYGhobmJh6WhMnCoAk8cqhg</recordid><startdate>20191016</startdate><enddate>20191016</enddate><creator>DANG KEVIN</creator><creator>HARRIS KATHERINE E</creator><creator>TRINKLEIN NATHAN</creator><creator>VANSCHOOTEN WIM</creator><creator>ALDRED SHELLEY FORCE</creator><scope>EVB</scope></search><sort><creationdate>20191016</creationdate><title>항-BCMA 중쇄-단독 항체</title><author>DANG KEVIN ; HARRIS KATHERINE E ; TRINKLEIN NATHAN ; VANSCHOOTEN WIM ; ALDRED SHELLEY FORCE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20190117489A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>kor</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>DANG KEVIN</creatorcontrib><creatorcontrib>HARRIS KATHERINE E</creatorcontrib><creatorcontrib>TRINKLEIN NATHAN</creatorcontrib><creatorcontrib>VANSCHOOTEN WIM</creatorcontrib><creatorcontrib>ALDRED SHELLEY FORCE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DANG KEVIN</au><au>HARRIS KATHERINE E</au><au>TRINKLEIN NATHAN</au><au>VANSCHOOTEN WIM</au><au>ALDRED SHELLEY FORCE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>항-BCMA 중쇄-단독 항체</title><date>2019-10-16</date><risdate>2019</risdate><abstract>본원에 기재된 항-BCMA 중쇄-단독 항체 (HCAb), 및 이러한 항체의 제조 방법, 조성물 (이러한 항체를 포함하는 약학적 조성물 포함), 및 BCMA의 발현을 특징으로 하는 B-세포 장애의 치료에 대한 이들의 사용. Anti-BCMA heavy chain-only antibodies (HCAb) and disclosed, along with methods of making such antibodies, compositions, including pharmaceutical compositions, comprising such antibodies, and their use to treat B-cell disorders characterized by the expression of BCMA.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language kor
recordid cdi_epo_espacenet_KR20190117489A
source esp@cenet
subjects CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
title 항-BCMA 중쇄-단독 항체
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T21%3A37%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DANG%20KEVIN&rft.date=2019-10-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20190117489A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true